Literature DB >> 27016303

The potential function of microRNA in chordomas.

Sukru Gulluoglu1, Emre Can Tuysuz2, Aysegul Kuskucu3, Ugur Ture4, Basar Atalay5, Fikrettin Sahin6, Omer Faruk Bayrak7.   

Abstract

Little is known about the molecular biology of chordomas, which are rare, chemoresistant tumors with no well-established treatment. miRNAs regulate gene networks and pathways. We aimed to evaluate the effects of dysregulated miRNA in chordomas would help reveal the underlying mechanisms of chordoma initiation and progression. In this study, miR-31, anti-miR-140-3p, anti-miR148a, and miR-222 were transiently transfected to chordoma cell lines and an MTS assay, apoptosis assay, and cell-cycle analysis were conducted to evaluate the effects. The mRNA level of predicted and confirmed targets of each miRNA, as well as the EMT and MET markers of U-CH1 and MUG-Chor1, were assessed with real-time polymerase chain reaction. Transient transfection of miRNA mimics was achieved, as each mimic increased or decreased the level of its corresponding miRNA. miR-31 decreased cell viability in MUG-Chor1 and U-CH2 after 72h, which is consistent with previous findings for U-CH1. Both miR-31 and anti-miR-148a induced apoptosis in all three cell lines. Although each miRNA had a similar pattern, miR-31 had the most effective S-phase arrest in all three cell lines. RDX, MET, DNMT1, DNMT3B, TRPS1, BIRC5, and KIT were found to be targeted by the selected miRNAs. The level of miR-222 in chordoma cell lines U-CH1 and MUG-Chor1 correlated positively with EMT markers and negatively with MET markers. This study uncovered the potential of miR-31, miR-140-3p, miR-148a, and miR-222-3p to be key molecules in the cell viability, cell cycle, and apoptosis in chordomas, as well as initiation, differentiation, and progression.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  EMT; KIT; Microarray; TRPS1; Target; miR-222

Mesh:

Substances:

Year:  2016        PMID: 27016303     DOI: 10.1016/j.gene.2016.03.032

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

1.  BRAFV600E Mutation-Responsive miRNA-222-3p Promotes Metastasis of Papillary Thyroid Cancer Cells via Snail-Induced EMT.

Authors:  Yuan Gao; Dapeng Xiang; Weijie Li; Xi Zheng; Lin Wang; Zhiyu Li; Ting Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-16       Impact factor: 6.055

2.  Emerging roles and mechanisms of microRNA‑222‑3p in human cancer (Review).

Authors:  Danhua Wang; Yiwen Sang; Tao Sun; Piaoping Kong; Lingyu Zhang; Yibei Dai; Ying Cao; Zhihua Tao; Weiwei Liu
Journal:  Int J Oncol       Date:  2021-03-24       Impact factor: 5.650

3.  Expression and Regulatory Network Analysis of miR-140-3p, a New Potential Serum Biomarker for Autism Spectrum Disorder.

Authors:  Matilde Cirnigliaro; Cristina Barbagallo; Mariangela Gulisano; Carla N Domini; Rita Barone; Davide Barbagallo; Marco Ragusa; Cinzia Di Pietro; Renata Rizzo; Michele Purrello
Journal:  Front Mol Neurosci       Date:  2017-08-10       Impact factor: 5.639

4.  Upregulation Of miR-149-3p Suppresses Spinal Chordoma Malignancy By Targeting Smad3.

Authors:  Jie Yao; Xuejian Wu
Journal:  Onco Targets Ther       Date:  2019-11-19       Impact factor: 4.147

5.  Potential molecular mechanism in self-renewal is associated with miRNA dysregulation in sacral chordoma - A next-generation RNA sequencing study.

Authors:  Arpad Bozsodi; Beata Scholtz; Gergo Papp; Zoltan Sapi; Adam Biczo; Peter Pal Varga; Aron Lazary
Journal:  Heliyon       Date:  2022-08-13

Review 6.  Translational Windows in Chordoma: A Target Appraisal.

Authors:  Samantha E Hoffman; Sally A Al Abdulmohsen; Saksham Gupta; Blake M Hauser; David M Meredith; Ian F Dunn; Wenya Linda Bi
Journal:  Front Neurol       Date:  2020-07-08       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.